2:30PM Pharmacodynamic & Clinical Activity of 4D-310 in Fabry Patients with Low Capsid-Neutralizing Factors Detected Using a Cell Based Assay
Time: 2:30 pm
day: Conference Day 1
Details:
• Examining the pharmacodynamics of 4D-310 and its ability to overcome immune responses in Fabry patients with low capsid-neutralizing factors
• Understanding the clinical activity of 4D-310 and its potential to improve patient outcomes in the context of Fabry disease
• Discussing the role of cell-based assays in detecting capsid-neutralizing factors and optimizing gene therapy strategies for patients with pre-existing immunity
